NO993928D0 - Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium - Google Patents

Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Info

Publication number
NO993928D0
NO993928D0 NO993928A NO993928A NO993928D0 NO 993928 D0 NO993928 D0 NO 993928D0 NO 993928 A NO993928 A NO 993928A NO 993928 A NO993928 A NO 993928A NO 993928 D0 NO993928 D0 NO 993928D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
quaternary ammonium
oral administration
heterocyclic compounds
heterocyclic
Prior art date
Application number
NO993928A
Other languages
Norwegian (no)
Other versions
NO993928L (en
Inventor
Jean-Claude Gautier
Xavier Boulenc
Regine Bellamy
Bernard Abramovici
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO993928D0 publication Critical patent/NO993928D0/en
Publication of NO993928L publication Critical patent/NO993928L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO993928A 1997-02-17 1999-08-16 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium NO993928L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701825A FR2759584B1 (en) 1997-02-17 1997-02-17 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF HETEROCYCLIC COMPOUNDS IN QUATERNARY AMMONIUM FORM
PCT/FR1998/000298 WO1998035662A1 (en) 1997-02-17 1998-02-17 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Publications (2)

Publication Number Publication Date
NO993928D0 true NO993928D0 (en) 1999-08-16
NO993928L NO993928L (en) 1999-08-16

Family

ID=9503804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993928A NO993928L (en) 1997-02-17 1999-08-16 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium

Country Status (11)

Country Link
EP (1) EP0969825A1 (en)
JP (1) JP2001511795A (en)
AR (1) AR011805A1 (en)
AU (1) AU6404998A (en)
BR (1) BR9807694A (en)
CA (1) CA2281560A1 (en)
FR (1) FR2759584B1 (en)
HR (1) HRP980075A2 (en)
NO (1) NO993928L (en)
WO (1) WO1998035662A1 (en)
ZA (1) ZA981289B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188424B (en) * 2011-03-23 2013-03-27 浙江理工大学 Anti-leukemia effects of SR140333

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676054B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2676055B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf AMINO POLYCYCLIC COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2688219B1 (en) * 1992-03-03 1994-07-08 Sanofi Elf AMATONIUM QUATERNARY SALTS OF AMINO AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2696178B1 (en) * 1992-09-30 1994-12-30 Sanofi Elf Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.
FR2717804B1 (en) * 1994-03-25 1996-06-21 Sanofi Sa Salts of substituted nitrogen heteroaromatic compounds, process for their preparation and pharmaceutical compositions containing them.
EP0777666B1 (en) * 1994-08-25 1999-03-03 Merrell Pharmaceuticals Inc. Substituted piperidines useful for the treatment of allergic diseases
FR2725986B1 (en) * 1994-10-21 1996-11-29 Adir NOVEL PIPERIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2725900B1 (en) * 1994-10-21 1997-07-18 Sanofi Sa USE OF NK1 RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS WITH CARDIOREGULATORY ACTION
FR2729951B1 (en) * 1995-01-30 1997-04-18 Sanofi Sa NOVEL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2729954B1 (en) * 1995-01-30 1997-08-01 Sanofi Sa SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
BR9807694A (en) 2000-03-21
EP0969825A1 (en) 2000-01-12
ZA981289B (en) 1998-08-26
HRP980075A2 (en) 1998-10-31
FR2759584B1 (en) 1999-06-11
AU6404998A (en) 1998-09-08
WO1998035662A1 (en) 1998-08-20
CA2281560A1 (en) 1998-08-20
AR011805A1 (en) 2000-09-13
JP2001511795A (en) 2001-08-14
FR2759584A1 (en) 1998-08-21
NO993928L (en) 1999-08-16

Similar Documents

Publication Publication Date Title
EE04578B1 (en) Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates
NO995809L (en) Pharmaceutical formulation of omeprazole
DK0876131T3 (en) Compositions for drug administration for improved stability of androgens
NO973479L (en) Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same
DE69634053D1 (en) Oral drug composition containing 2-methyl-thienobenzodiazepine
NO994757D0 (en) Procedure for Oral Administration of Proteins
EE9700241A (en) Pharmaceutical composition for transdermal administration
NO996372D0 (en) Solid pharmaceutical preparation containing benzofuan derivatives
EE03177B1 (en) Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds
NO973938L (en) Pharmaceutical preparation of piperidinoalkanol compounds
NO20012248D0 (en) Pharmaceutical preparation of moxifloxacin
NO953367L (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs
NO20041007L (en) Use of oxypurine nucleosides for the preparation of a pharmaceutical composition
EE200000226A (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
BR9610530A (en) Heteroaryl substituted acryloylguanidine derivatives and pharmaceutical compositions containing the same
NO308236B1 (en) Pharmaceutical composition containing indole derivatives
NO20001717D0 (en) Serotonin-containing formulation for oral administration and use of the same
EE9900206A (en) Pharmaceutical compositions containing N-sulfonylindoline derivatives
NO975680L (en) Oral pharmaceutical preparation of piperidinoalkanol compounds in solution form
FR2759585B1 (en) PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
BR9607433A (en) Pharmaceutical composition for parental administration
EE04095B1 (en) Use of ketolides and pharmaceutically acceptable salts thereof for the preparation of pharmaceutical compositions
NO993928D0 (en) Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
NO20003393D0 (en) Process for the preparation of a pharmaceutical formulation
ITMI913510A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH BIOAVAILABILITY PROGESTERONE